LINC00511 and cancer: Moreover, LINC00324, with a fold-change = 3.6 (FDR = 0.0022, Fig 3B), and LINC00511 (fold-change = 1.81, FDR = 0.0196), have been characterized in comprehensive efforts to understand the functions of such molecules in cancer [28], potentially acting as bona fide oncogenes [29]